Novonesis (Novozymes) B Novonesis (Novozymes) B

Novonesis (Novozymes) B

NSISBC

Kedudukan dalam Saham #1158
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Harga Saham
$70.10
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$19.48B
Perubahan (1 hari)
-4.64%
Perubahan (1 tahun)
10.57%
Negara
DK
Perdagangan Novonesis (Novozymes) B (NSISBC)

Kategori

Basic Materials
Sejarah hasil dividen untuk Novonesis (Novozymes) B (NSISBC)
Hasil dividen (TTM) bagi Novonesis (Novozymes) B (simbol saham: NSISBC) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Novonesis (Novozymes) B (NSISBC) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Linde plc Linde plc
Linde plc
LIN.US
1.28%
GB
L'Air Liquide S.A. L'Air Liquide S.A.
L'Air Liquide S.A.
AI.PA
0.00%
FR
The Sherwin-Williams Company The Sherwin-Williams Company
The Sherwin-Williams Company
SHW.US
0.98%
US
Ecolab Inc. Ecolab Inc.
Ecolab Inc.
ECL.US
1.01%
US
Air Products and Chemicals, Inc. Air Products and Chemicals, Inc.
Air Products and Chemicals, Inc.
APD.US
2.47%
US